{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:43:59Z","timestamp":1790232239072,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/aog.0000000000000285","type":"journal-article","created":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T11:13:36Z","timestamp":1399461216000},"page":"1177-1184","source":"Crossref","is-referenced-by-count":74,"title":["Trends in Glyburide Compared With Insulin Use for Gestational Diabetes Treatment in the United States, 2000\u20132011"],"prefix":"10.1097","volume":"123","author":[{"given":"Wendy","family":"Camelo Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Boggess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Til","family":"St\u00fcrmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Alan","family":"Brookhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Jonsson Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210126","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.diabres.2012.09.002","article-title":"Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment.","volume":"98","author":"Falavigna","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 1","key":"R2-6-20210126","first-page":"S88","article-title":"Gestational diabetes mellitus.","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"R3-6-20210126","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e318278ce86","article-title":". Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007.","volume":"121","author":"Lawrence","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R4-6-20210126","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1080\/00016340802443863","article-title":"Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: current knowledge and metabolic effects on the offspring.","volume":"87","author":"Devlieger","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R5-6-20210126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajog.2005.12.005","article-title":"Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety.","volume":"195","author":"Kraemer","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R6-6-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0890-6238(01)00122-8","article-title":"Glyburide and fetal safety; transplacental pharmacokinetic considerations.","volume":"15","author":"Koren","year":"2001","journal-title":"Reprod Toxicol"},{"key":"R7-6-20210126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/clpt.2009.5","article-title":". Are we optimizing gestational diabetes treatment with glyburide The pharmacologic basis for better clinical practice.","volume":"85","author":"Hebert","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R8-6-20210126","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.jp.7210759","article-title":"Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis.","volume":"22","author":"Goetzl","year":"2002","journal-title":"J Perinatol"},{"key":"R9-6-20210126","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus.","volume":"343","author":"Langer","year":"2000","journal-title":"N Engl J Med"},{"key":"R10-6-20210126","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4158\/EP.13.4.427","article-title":"Comparison of glyburide versus insulin in management of gestational diabetes mellitus.","volume":"13","author":"Ogunyemi","year":"2007","journal-title":"Endocr Pract"},{"key":"R11-6-20210126","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1515\/JPM.2005.092","article-title":"Perinatal outcomes and the use of oral hypoglycemic agents.","volume":"33","author":"Bertini","year":"2005","journal-title":"J Perinat Med"},{"key":"R12-6-20210126","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajog.2005.03.018","article-title":"Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.","volume":"193","author":"Jacobson","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R13-6-20210126","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.jp.7211683","article-title":"Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.","volume":"27","author":"Ramos","year":"2007","journal-title":"J Perinatol"},{"key":"R15-6-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14450","article-title":". Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee.","volume":"14","author":"Waugh","year":"2010","journal-title":"Health Technol Assess"},{"key":"R16-6-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/AOG.0b013e318190a459","article-title":"Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review.","volume":"113","author":"Nicholson","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R18-6-20210126","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis.","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"R20-6-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.AOG.0000129239.82126.a1","article-title":"Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy.","volume":"104","author":"Yogev","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R21-6-20210126","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1464-5491.2011.03326.x","article-title":"Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG).","volume":"28","author":"Ogunyemi","year":"2011","journal-title":"Diabet Med"},{"key":"R22-6-20210126","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/14767058.2010.531323","article-title":"Glyburide in gestational diabetesprediction of treatment failure.","volume":"24","author":"Yogev","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R23-6-20210126","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ajog.2006.07.029","article-title":"Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes.","volume":"195","author":"Rochon","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R24-6-20210126","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/01.AOG.0000218704.28313.36","article-title":"Predictors of glyburide failure in the treatment of gestational diabetes.","volume":"107","author":"Kahn","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R25-6-20210126","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.jp.7211147","article-title":"Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus.","volume":"24","author":"Chmait","year":"2004","journal-title":"J Perinatol"},{"issue":"Suppl 1","key":"R26-6-20210126","first-page":"336","article-title":"Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaska native women.","volume":"187","author":"Gilson","year":"2012","journal-title":"Am J Obstet Gynaecol"},{"key":"R27-6-20210126","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/pds.2217","article-title":"Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy.","volume":"20","author":"Andrade","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R28-6-20210126","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/dc09-1801","article-title":". Diabetes trends among delivery hospitalizations in the U.S., 1994-2004.","volume":"33","author":"Albrecht","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000000285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:17:50Z","timestamp":1620944270000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201406000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000285","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}